CYBERMED NEWS - Higher Medical Scientifc Information and Research

HEALTH

CBD clampdown could be reversed as EU hears new evidence

Written by CYBERMED NEWS
facebook Share on Facebook
CBD clampdown could be reversed as EU hears new evidence image

The clampdown on CBD (cannabidiol) oils—which would have seen products removed from shelves throughout the 28 countries of the European Union (EU)—is being reconsidered.

The EU had planned to ban from sale all CBD products for at least 18 months while their safety was evaluated. The products fell into the EU's 'novel foods' category, which includes supplements and therapeutic remedies that have been used only since 1997 and their safety hasn't been properly tested.

 

But the European Food Safety Association is reconsidering the decision after hearing evidence that hemp and hemp extracts have been used since 1220, and their safety has been well established.

The European Industrial Hemp Association (EIHA) submitted evidence to the association that demonstrated the safe long-term use of hemp in many societies.

The World Health Organization has already given its endorsement to CBD. As CBD is the therapeutic part of cannabis that doesn't have addictive qualities, there haven't been any reports of CBD abuse or addiction, the WHO has said.

People are using CBD oils to help treat pain, anxiety and epilepsy.

https://www.wddty.com/news/2019/03/cbd-clampdown-could-be-reversed-as-eu-hears-new-evidence.html?utm_source=Boomtrain&utm_medium=email&utm_campaign=enews_25032019&bt_ee=g2XjfET%2FMz%2BXWpKjbxDgv0MxBpk1bpBXZJEy%2BCzDJaQvN%2BDjDc429X5qU4FbqfL0&bt_ts=1553519043030


Related Articles

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.